logo

For the Inventor, By the Inventor

Calgary, Canada

Kaveh Matinkhoo

USPTO Granted Patents = 11 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal10 out of 23 
 
Enveric Biosciences Canada Inc.
 patents
silverMedal1 out of 1 
 
Enveric Biosciences Canadainc.
 patent

Years Active: 2023-2025

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12492179 - Substituted ethylamine fused heterocyclic mescaline derivatives (2025-12-09),
2. 12428408 - Fused heterocyclic mescaline derivatives (2025-09-30),
3. 12358885 - Substituted n-propylamine fused heterocyclic mescaline derivatives (2025-07-15),
4. 12338231 - N-heterocycle substituted tryptamine derivatives and methods of using (2025-06-24),
5. 12195439 - C1-substituted isopropylamine fused heterocyclic mescaline derivatives (2025-01-14),
6. 12077498 - C4-carboxylic acid-substituted tryptamine derivatives and methods of using (2024-09-03),
7. 12065404 - C4-carboxylic acid-substituted tryptamine derivatives and methods of using (2024-08-20),
8. 11945778 - C-carbonothioate-substituted tryptamine derivatives and methods of using (2024-04-02),
9. 11845726 - C-carbonothioate-substituted tryptamine derivatives and methods of using (2023-12-19),
10. 11746087 - C4-carboxylic acid-substituted tryptamine derivatives and methods of using (2023-09-05),
11. 11707447 - C4-carbonothioate-substituted tryptamine derivatives and methods of using (2023-07-25),

Title: Kaveh Matinkhoo: Innovator in Fused Heterocyclic Mescaline Derivatives

Introduction

Kaveh Matinkhoo is a prominent inventor based in Calgary, Canada. He has made significant contributions to the field of pharmaceutical and recreational drug formulations. With a total of 10 patents to his name, Matinkhoo is recognized for his innovative approaches to drug development.

Latest Patents

Among his latest patents are the "Fused Heterocyclic Mescaline Derivatives," which disclose novel compounds and methods for creating pharmaceutical and recreational drug formulations. Another notable patent is the "Substituted N-Propylamine Fused Heterocyclic Mescaline Derivatives," which also includes methods for making and using these innovative compounds. These patents highlight Matinkhoo's focus on advancing drug formulation technologies.

Career Highlights

Throughout his career, Kaveh Matinkhoo has worked with Enveric Biosciences Canada Inc., where he has contributed to various research and development projects. His work has been instrumental in exploring new avenues for drug formulations that could potentially benefit both medical and recreational users.

Collaborations

Matinkhoo has collaborated with notable professionals in the field, including Jillian M. Hagel and Peter James Facchini. These collaborations have further enriched his research and development efforts.

Conclusion

Kaveh Matinkhoo stands out as an innovative inventor in the realm of drug formulation, with a strong portfolio of patents that reflect his dedication to advancing pharmaceutical science. His contributions are paving the way for new possibilities in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…